血管移植市场－全球产业规模、份额、趋势、机会和预测（按产品、应用、地区和竞争细分，2020-2030 年）

2024 年全球血管移植市场价值为 12.9 亿美元，预计到 2030 年将达到 19.7 亿美元，预测期内复合年增长率为 7.31%。市场正在经历强劲成长，主要是由于週边动脉疾病（PAD）、动脉瘤和冠状动脉疾病（CAD）等血管疾病的盛行率不断上升。这些情况涉及血管狭窄或阻塞，可能导致中风、心肌梗塞和肢体缺血等严重併发症，因此需要使用血管移植进行手术介入。此外，冠状动脉绕道手术（CABG）和血管内动脉瘤修復（EVAR）等手术数量的增加也进一步支持了需求。血管移植在这些手术中透过替换或绕过受损的血管发挥着至关重要的作用。技术进步和产品创新也在推动市场的发展。例如，2022年5月，加州大学戴维斯分校获得加州再生医学研究所300万美元的资助，用于开发用于血液透析患者的下一代血管移植物。这些发展反映了利害关係人对提高移植物性能和寿命的持续承诺，预计这将在未来几年显着推动市场成长。

关键市场驱动因素

心血管疾病盛行率不断上升

主要市场挑战

严格的监管障碍

主要市场趋势

技术进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球血管移植市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（血液透析通路移植、血管内支架移植、週边血管移植、冠状动脉绕道移植）
  • 依应用（动脉瘤、肾衰竭、血管闭塞、冠状动脉疾病、其他应用）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美血管移植市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲血管移植市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太血管移植市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲血管移植市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲血管移植市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Abbott Laboratories
• Braun Melsungen AG
• Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• Cardinal Health (Cordis Corporation)
• Cook Medical
• Endologix Inc.
• Getinge Group
• LeMaitre Vascular Inc.
• Medtronic PLC
• Terumo Medical Corporation.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Vascular Graft Market was valued at USD 1.29 Billion in 2024 and is anticipated to reach USD 1.97 Billion by 2030, growing at a CAGR of 7.31% during the forecast period. The market is witnessing strong growth, primarily due to the increasing prevalence of vascular disorders such as peripheral artery disease (PAD), aneurysms, and coronary artery disease (CAD). These conditions, which involve the narrowing or blockage of blood vessels, can lead to critical complications like stroke, myocardial infarction, and limb ischemia, thereby necessitating surgical interventions using vascular grafts. Additionally, the rising volume of procedures such as coronary artery bypass grafting (CABG) and endovascular aneurysm repair (EVAR) has further supported demand. Vascular grafts play a crucial role in these surgeries by replacing or bypassing damaged blood vessels. Technological progress and product innovation are also advancing the market. For example, in May 2022, UC Davis received a USD 3 million grant from the California Institute for Regenerative Medicine to develop a next-generation vascular graft for hemodialysis patients. Such developments reflect the ongoing commitment of stakeholders to enhance the performance and longevity of grafts, which is expected to significantly boost market growth in the coming years.

Key Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The global vascular graft market is primarily driven by the escalating incidence of cardiovascular conditions such as coronary artery disease, peripheral arterial disease, and aortic aneurysms. These diseases represent a growing health concern worldwide, largely attributed to sedentary lifestyles, unhealthy diets, and an aging population. As more individuals develop comorbidities like hypertension, diabetes, and obesity, the risk of cardiovascular events increases, fueling the need for surgical interventions involving vascular grafts. This surge in disease burden directly correlates with rising demand for procedures like CABG and EVAR, where vascular grafts are essential for restoring adequate blood flow. As a result, the demand for graft-based solutions is set to grow steadily, supporting overall market expansion.

Key Market Challenges

Stringent Regulatory Hurdles

A significant challenge in the vascular graft market lies in the rigorous regulatory landscape governing medical devices. Organizations such as the U.S. FDA and EMA mandate thorough evaluations to ensure the safety and efficacy of vascular grafts, including extensive clinical trials and quality testing. While such standards are crucial for safeguarding public health, they contribute to extended development timelines and higher compliance costs. This can be particularly burdensome for smaller firms with limited resources, ultimately restricting the pace of innovation and delaying patient access to new products. Additionally, the need to navigate varying regulatory frameworks across different countries complicates global product approvals and increases market entry barriers for manufacturers.

Key Market Trends

Technological Advancements

Continuous innovation in graft materials and design is a key trend shaping the vascular graft market. Advanced materials, such as bioengineered and tissue-engineered grafts, have significantly enhanced the safety and performance of these products by improving biocompatibility and reducing the risk of complications. Furthermore, grafts featuring anti-thrombogenic and anti-infective coatings are gaining traction, offering better outcomes in terms of long-term patency and infection prevention. These developments not only improve surgical success rates but also enable wider application of vascular grafts in complex procedures. As technologies evolve, next-generation grafts are expected to play a more prominent role in vascular surgeries, encouraging wider clinical adoption and contributing to market growth.

Key Market Players

• Abbott Laboratories
• Braun Melsungen AG
• Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• Cardinal Health (Cordis Corporation)
• Cook Medical
• Endologix Inc.
• Getinge Group
• LeMaitre Vascular Inc.
• Medtronic PLC
• Terumo Medical Corporation

Report Scope:

In this report, the Global Vascular Graft Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vascular Graft Market, By Product:

• Hemodialysis Access Graft Endovascular Stent Graft
• Peripheral Vascular Graft
• Coronary Artery By-pass Graft

Vascular Graft Market, By Drug Application:

• Aneurysms
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Diseases
• Other Applications

Vascular Graft Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market.

Available Customizations:

Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vascular Graft Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft)
  • 5.2.2. By Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, Other Applications)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Vascular Graft Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vascular Graft Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Vascular Graft Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Vascular Graft Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Vascular Graft Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Vascular Graft Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Vascular Graft Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Vascular Graft Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Vascular Graft Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Vascular Graft Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Vascular Graft Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vascular Graft Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Vascular Graft Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Vascular Graft Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Vascular Graft Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Vascular Graft Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Vascular Graft Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vascular Graft Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Vascular Graft Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Vascular Graft Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Vascular Graft Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vascular Graft Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Vascular Graft Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Vascular Graft Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Braun Melsungen AG
• 15.3. Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• 15.4. Cardinal Health (Cordis Corporation)
• 15.5. Cook Medical
• 15.6. Endologix Inc.
• 15.7. Getinge Group
• 15.8. LeMaitre Vascular Inc.
• 15.9. Medtronic PLC
• 15.10. Terumo Medical Corporation.

16. Strategic Recommendation

17. About Us & Disclaimer